GLP-1 weight loss trend

L’utilisation d’Ozempic et de médicaments similaires a triplé chez les non-diabétiques, selon une étude

De plus en plus d’Américains se tournent vers des médicaments contre le diabète comme Ozempic, non pas pour traiter le diabète, mais pour perdre du poids. Une nouvelle étude révèle que l’utilisation des médicaments GLP-1 par des adultes américains sans diabète a plus que triplé entre 2018 et 2022. Durant cette période, les dépenses annuelles

cinnamon

Prediabetics May Benefit from Taking Cinnamon Supplements

In a recent randomized, controlled, double-blind trial, researchers in the United States investigated the impact of a modest daily intake of 4g of cinnamon supplements over four weeks on blood glucose levels. The study, extended with continuous glucose monitoring (CGM) and oral glucose tolerance test (OGTT) data, focused on participants with obesity and prediabetes. Contradictory

New Study Results Published – Lilly GZGI

Two new phase 2 studies suggest that the investigational drug orforglipron, developed by Eli Lilly, shows promise in the treatment of obesity and type 2 diabetes. Currently, GLP-1 agonists (a class of medications utilized in the treatment of type 2 diabetes mellitus and obesity) approved for these conditions are administered via under the skin injection,

Are Autoimmune Diseases Becoming More Common?

A new population-based study, involving 22 million people, shows that autoimmune disorders now affect around one in ten individuals. These conditions pose a huge burden on individuals and upon wider society, and currently represent an enormous unmet clinical need. Autoimmune diseases are a group of disorders characterized by an abnormal immune response, where the immune